Clinical Trials Directory

Trials / Unknown

UnknownNCT04662853

Gut Microbiota and Color-rectal Cancer.

Gut Microbiota-based Tool for the Detection of Color-rectal Cancer in Positive Patients for the Fecal Occult Blood Test.

Status
Unknown
Phase
Study type
Observational
Enrollment
153 (actual)
Sponsor
Maimónides Biomedical Research Institute of Córdoba · Academic / Other
Sex
All
Age
50 Years – 69 Years
Healthy volunteers
Not accepted

Summary

This clinical trial is focused in the development of a screening test for the people at risk of colo-rectal cancer (aged more than 50 years old), valid and safe, improving the screening prognosis increasing the sensitivity and sensitive as compared with the current method, fecal occult blood.

Detailed description

Colo-rectal cancer (CCR) is one of the most prevalent cancers in developed countries. Several studies suggest that the CCR may be related with changes in the gut microbiota. This clinical trial is focused in the development of a screening test for the people at risk of CCR (aged more than 50 years old), valid and safe, improving the screening prognosis. The main potential improvement lies in the fact that the proposed method is more specific and sensitive than the current method, fecal occult blood. It aims to distinguish whether the positive results for fecal occult blood test is due to fissures, not related with CCR (which are positive for fecal occult blood, false positive) or was caused by a cancer-related lesion. The methodology derived will also improve the sensitive as sometimes the polyps do not leak blood. Based in the previous differences found in the gut microbiota composition related with CCR for several research groups, the gut microbiota composition will be used as diagnosis tool.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGut microbiota determination from feces samples.Determination of the gut microbiota composition by 16S metagenomic and building of a mathematical model, on the basis of the colonoscopies results, able to classify patients without and with color-rectal cancer-related lessions. These latter will be also classified according to the type of lession.

Timeline

Start date
2017-01-17
Primary completion
2021-07-31
Completion
2021-07-31
First posted
2020-12-10
Last updated
2020-12-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04662853. Inclusion in this directory is not an endorsement.